AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment

Food and Drug ​Administration has approved ‌Daiichi Sankyo's therapy in combination ‌with Roche's drug for the first-line ...
Targeted Oncology

Deep Proteomic, AI Breast Cancer Detection Test Demonstrates High Performance

The test, developed by Astrin Biosciences, utilizes deep proteomic profiling and a machine learning classifier to identify ...

Roche Gets Expanded FDA Approval for Breast-Cancer Test

Roche received expanded approval from the Food and Drug Administration for a test to diagnose breast cancer. The pharmaceutical company said Monday that the FDA approved the PATHWAY HER2 (4B5) test ...
The Malaysian Reserve

Roche receives FDA approval for first diagnostic tests to identify HER2-positive metastatic breast cancer patients eligible for ENHERTU

FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used ...
Precision Medicine Online

Circulating Tumor DNA Treatment Tailoring Making Progress in Breast Cancer, But More Studies Needed

Experts at SABCS said better prospective trials of ctDNA and more sensitive assays could bring ctDNA testing closer to the ...
Precision Medicine Online

AstraZeneca, Daiichi Sankyo's Enhertu Approved for First-Line HER2-Positive Breast Cancer

The FDA's approval is based on results from the Phase III DESTINY-Breast09 trial, in which the combo showed a median 40.7-month progression-free survival.